These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1967313)

  • 1. Synthesis and beta-adrenergic antagonist activity of stereoisomeric practolol and propranolol derivatives.
    Leftheris K; Goodman M
    J Med Chem; 1990 Jan; 33(1):216-23. PubMed ID: 1967313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro pharmacologic activity of congener derivatives and model conjugates of propranolol and practolol.
    Khan MM; Marr-Leisy D; Rosenkranz R; Hoffman BB; Verlander MS; Goodman M; Melmon KL
    Biochem Pharmacol; 1987 Jul; 36(13):2175-82. PubMed ID: 3038116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biologic distribution of radioiodinated beta-adrenergic antagonists.
    Hanson RN; Holman BL; Davis MA
    J Med Chem; 1978 Aug; 21(8):830-3. PubMed ID: 29126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bivalent ligand type beta-adrenolytics related to practolol.
    Rampa A; Da Re P; Valenti P; Frigeni V; Sala R; Della Bella D
    Drugs Exp Clin Res; 1988; 14(9):581-6. PubMed ID: 2906585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
    Levy JV
    Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonspecific membrane effects of CH-103: hydrophobicity, surface activity and membrane fluidity studies in comparison with propranolol and practolol.
    Varga E; Szöllösi J; Antal K; Kovács P; Szabó JZ
    Pharmazie; 1999 May; 54(5):380-4. PubMed ID: 10368833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of beta-adrenoceptors in right atrium, diaphragm and adipose tissue of the rat, using stereoisomers of propranolol, alprenolol, nifenalol and practolol.
    Harms HH; Zaagsma J; de Vente J
    Life Sci; 1977 Jul; 21(1):123-8. PubMed ID: 196150
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.
    Bodem G; Brammell HL; Weil JV; Chidsey CA
    J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arylethanolamines derived from salicylamide with alpha- and beta-adrenoceptor blocking activities. Preparation of labetalol, its enantiomers, and related salicylamides.
    Clifton JE; Collins I; Hallett P; Hartley D; Lunts LH; Wicks PD
    J Med Chem; 1982 Jun; 25(6):670-9. PubMed ID: 6124636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential inhibition of lipolysis in human adipose tissue by adrenergic beta receptor blocking drugs.
    Frisk-Holmberg M; Ostman J
    J Pharmacol Exp Ther; 1977 Mar; 200(3):598-605. PubMed ID: 15099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenoceptor studies. III. On the beta-adrenoceptors in rat adipose tissue.
    Harms HH; Zaagsma J; Van der Wal B
    Eur J Pharmacol; 1974 Jan; 25(1):87-91. PubMed ID: 4154848
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of beta adrenergic blocking agents on erythropoietin production in rabbits exposed to hypoxia.
    Fink GD; Paulo LG; Fisher JW
    J Pharmacol Exp Ther; 1975 Apr; 193(1):176-81. PubMed ID: 237111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological evaluation of propranolol-cyclic analogues.
    Castagnino E; Corsano S; Strappaghetti G; Brasili L; Gallucci P
    Farmaco Sci; 1983 Sep; 38(9):679-85. PubMed ID: 6139297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoprenaline- and exercise- induced tachycardia in the assessment of beta-adrenoceptor blocking drugs; a comparison between tolamolol, practolol and propranolol.
    Adam KR; Pullman LG; Scholfield PC
    Br J Pharmacol; 1973 Nov; 49(3):560-3. PubMed ID: 4149697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute configuration by asymmetric synthesis of (+)-1-(4-acetamidophenoxy)-3-(isopropylamino)-propan-z-ol (practolol).
    Danilewicz JC; Kemp JE
    J Med Chem; 1973 Feb; 16(2):168-9. PubMed ID: 4405110
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal effects of propranolol, practolol and butoxamine in pentobarbital-anesthetized rats.
    Shibouta Y; Nishikawa K; Kikuchi S; Shimamoto K
    Eur J Pharmacol; 1979 Jan; 53(2):201-8. PubMed ID: 759198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-Adrenergic blocking agents. 23. 1-[Substituted-amido)phenoxy]-3-[[(substituted-amido)alkyl]amino] propan-2-ols.
    Large MS; Smith LH
    J Med Chem; 1983 Mar; 26(3):352-7. PubMed ID: 6131134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypotensive action of OPC-1427, a new beta-adrenergic blocking agent in rats.
    Sugawara K; Takami N; Ozaki M
    Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):294-304. PubMed ID: 41497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some adrenergic beta-blocking agents affecting lipolysis in human adipose tissue in vitro.
    Wenkeová J; Kuhn E; Wenke M
    Eur J Pharmacol; 1976 May; 37(1):91-5. PubMed ID: 6293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the rigidification of propranolol, a mixed
    Franchini S; Sorbi C; Linciano P; Brasili L; Tait A
    Pharmazie; 2019 Mar; 74(3):131-135. PubMed ID: 30961676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.